Similar articles

• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  Mol JA. Mol JA. Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):679; author reply 679. Ned Tijdschr Geneeskd. 2003. PMID: 12712655 Dutch. No abstract available.
• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  Scheepmaker AJ, Horstink MW, Hoefnagels WH, Strijks FE. Scheepmaker AJ, et al. Ned Tijdschr Geneeskd. 2003 Jan 4;147(1):32-5. Ned Tijdschr Geneeskd. 2003. PMID: 12564296 Dutch.
• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  de Haan HM. de Haan HM. Ned Tijdschr Geneeskd. 2003 Jun 21;147(25):1244. Ned Tijdschr Geneeskd. 2003. PMID: 12848063 Dutch. No abstract available.
• Brief review: rivastigmine, a second cholinesterase inhibitor.

  Patterson C, Hogan DB. Patterson C, et al. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293. Can J Neurol Sci. 2001. PMID: 11237306 Review. No abstract available.
• The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.

  Bullock R. Bullock R. Int J Clin Pract. 2002 Apr;56(3):206-14. Int J Clin Pract. 2002. PMID: 12018828 Review.